Akèy › Maladi Alzheimer › Kalifòni
Etid klinik pou Maladi Alzheimer nan Kalifòni
48 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
- Los Angeles14 etid
- San Diego12 etid
- Irvine11 etid
- Long Beach8 etid
- Orange7 etid
- Anaheim7 etid
- San Francisco7 etid
- Mountain View6 etid
- Concord5 etid
- Santa Ana4 etid
- Oakland4 etid
- Chino3 etid
- Murrieta3 etid
- Riverside3 etid
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Anaheim
- Clinical Site, Long Beach
- Clinical Site, Murrieta
- ak 2 plis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Advanced Research Center, Inc, Anaheim
- Sunwise Clinical Research, Walnut Creek
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1657, Anaheim
- Local Institution - 1668, Fresno
- Local Institution - 2625, Long Beach
- ak 6 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Progeny Psychiatric Clinic - Irvine, Irvine
- ATP Clinical Research, Inc - Orange, Orange
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- CenExel ACT (Formerly Anaheim Clinical Trials; LLC), Anaheim
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 24, 2026 · NCT07780383A Study of LY3439539 in Participants With Alzheimer's Disease
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- Inglewood Clinical, Los Angeles
- ak 1 plis
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Profound Research LLC, Carlsbad
- Irvine Clinical Research, Irvine
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
- ak 1 plis
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Oakland Clinical- Site Number : 8400010, Oakland
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Advanced Research Center, Inc., Anaheim
- Inland Psychiatric Medical Group (IPMG)-Chino, Chino
- USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Predicting Pre-dementia
- Foster Carr MD, San Diego
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07516119Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Esperanza Clinical, Murrieta
- Oakland Clinical Research, Oakland
- ATP Clinical Research, Inc., Orange
- ak 2 plis
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Sun Valley Research Center, Inc., Imperial
- Irvine Center for Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- ak 5 plis
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Irvine Center for Clinical Research /ID# 277752, Irvine
Ap rekriteFaz 1/2
Laj 50 a 90 · Tout sèks · Mizajou Sep 18, 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Fullerton Neurology and Headache Center, Fullerton
- Irvine Clinical Research, Irvine
- Inglewood Clinical, Los Angeles
- ak 1 plis
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- National Institute of Clinical Research, Garden Grove
- Local Institution - 2607, Long Beach
- Accellacare, Long Beach
- ak 4 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Advanced Research Center (ARC) - Anaheim, Anaheim
- Local Institution - 1668, Fresno
- The Neurology Group, Pomona
- ak 1 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011732A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Irvine Center for Clinical Research, Irvine
- Syrentis Clinical Research, Santa Ana
Ap rekriteFaz 3
Laj 55 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07717411Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Saddleback Medical Center, Orange
Ap rekrite
Laj 70 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05929703Alzheimer's Tau Platform: Master Protocol
- University of California, San Francisco, San Francisco
Ap rekriteFaz 2
Laj 50 a 80 · Tout sèks · Mizajou Sep 8, 2026 · NCT06957418Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
- UCLA TMS Clinical and Research Service, Los Angeles
Ap rekriteFaz 1/2
Laj 55 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT06597942Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0017, Anaheim
- Inland Psychiatric Medical Group., Chino
- Kaizen Brain Center, La Jolla
- ak 3 plis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Irvine Clinical Research ( Site 1041), Irvine
- Healthy Brain Clinic ( Site 1005), Long Beach
- Inglewood Clinical ( Site 1062), Los Angeles
- ak 3 plis
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- Stanford Medical Center, Palo Alto
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07178210A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Healthy Brain Clinic, Long Beach
- Anderson Clinical Research, Redlands
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan
- The Neurology Center of Southern California, Carlsbad
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Aug 17, 2026 · NCT07763392Senicapoc in Alzheimer's Disease
- University of California, Davis Alzheimer's Disease Center, Sacramento
- UC Davis Alzheimer's Disease Center East Bay, Walnut Creek
Ap rekriteFaz 2Volontè an sante akeyi
Laj 55 a 85 · Tout sèks · Mizajou Aug 17, 2026 · NCT04804241Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of California, San Diego (UCSD) - Medical Center, La Jolla
- University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of California San Diego Medical Center, La Jolla
- University of Southern Califonria, Los Angeles
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of California San Diego Medical Center, La Jolla
- University of Southern Califonria, Los Angeles
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Care Access - Huntington Beach, Huntington Beach
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- ak 6 plis
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Inland Psychiatric Medical Group., Chino
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Jun 30, 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Irvine Center for Clinical Research, Irvine
- University of California San Diego, La Jolla
- University of California at Los Angeles, Los Angeles
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516Polyphenols and Cognitive Decline
- University of California, Los Angeles, Los Angeles
Ap rekriteVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06507254A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Collaborative Neuroscience Network - CNS, Los Alamitos
Ap rekriteFaz 1Volontè an sante akeyi
Laj 45 a 85 · Tout sèks · Mizajou Jun 4, 2026 · NCT06657768TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
- Shiley Marcos Alzheimer's Disease Center, San Diego
Ap rekriteFaz 1Volontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06548191[18F]PI-2620 Phase 3 Histopathological Study
- UC Los Angeles, Los Angeles
- Esperanza Clinical, Murrieta
- Sutter Health, San Francisco
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- University of California, Irvine School of Medicine, Co-Enrolling through ABC-DS Only, Orange
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109Cardiac-Control Affecting Learning Through Mindfulness (CALM)
- University of Southern California, Los Angeles
Ap rekriteVolontè an sante akeyi
Laj 50 a 70 · Tout sèks · Mizajou May 13, 2026 · NCT06410157Biomarker Exploration in Aging, Cognition and Neurodegeneration
- University of California, Irvine, Irvine
Ap rekriteFaz 3Volontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT03860857Bumetanide in Patients With Alzheimer's Disease
- Stanford University, Stanford
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jan 14, 2026 · NCT06052163Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.